[English] 日本語

- PDB-5flc: Architecture of human mTOR Complex 1 - 5.9 Angstrom reconstruction -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 5flc | ||||||
---|---|---|---|---|---|---|---|
Title | Architecture of human mTOR Complex 1 - 5.9 Angstrom reconstruction | ||||||
![]() |
| ||||||
![]() | TRANSFERASE / RAPAMYCIN / MTORC1 | ||||||
Function / homology | ![]() RNA polymerase III type 2 promoter sequence-specific DNA binding / RNA polymerase III type 1 promoter sequence-specific DNA binding / positive regulation of cytoplasmic translational initiation / T-helper 1 cell lineage commitment / positive regulation of pentose-phosphate shunt / regulation of locomotor rhythm / positive regulation of wound healing, spreading of epidermal cells / TORC2 signaling / TORC2 complex / regulation of membrane permeability ...RNA polymerase III type 2 promoter sequence-specific DNA binding / RNA polymerase III type 1 promoter sequence-specific DNA binding / positive regulation of cytoplasmic translational initiation / T-helper 1 cell lineage commitment / positive regulation of pentose-phosphate shunt / regulation of locomotor rhythm / positive regulation of wound healing, spreading of epidermal cells / TORC2 signaling / TORC2 complex / regulation of membrane permeability / cellular response to leucine starvation / heart valve morphogenesis / negative regulation of lysosome organization / TFIIIC-class transcription factor complex binding / TORC1 complex / positive regulation of transcription of nucleolar large rRNA by RNA polymerase I / calcineurin-NFAT signaling cascade / voluntary musculoskeletal movement / regulation of osteoclast differentiation / RNA polymerase III type 3 promoter sequence-specific DNA binding / positive regulation of keratinocyte migration / regulation of lysosome organization / Amino acids regulate mTORC1 / cellular response to L-leucine / MTOR signalling / cellular response to nutrient / regulation of autophagosome assembly / Energy dependent regulation of mTOR by LKB1-AMPK / TORC1 signaling / energy reserve metabolic process / ruffle organization / serine/threonine protein kinase complex / negative regulation of cell size / cellular response to methionine / positive regulation of ubiquitin-dependent protein catabolic process / inositol hexakisphosphate binding / cellular response to osmotic stress / anoikis / negative regulation of protein localization to nucleus / cardiac muscle cell development / negative regulation of calcineurin-NFAT signaling cascade / regulation of myelination / positive regulation of transcription by RNA polymerase III / positive regulation of actin filament polymerization / negative regulation of macroautophagy / regulation of cell size / Macroautophagy / positive regulation of myotube differentiation / Constitutive Signaling by AKT1 E17K in Cancer / oligodendrocyte differentiation / germ cell development / behavioral response to pain / TOR signaling / mTORC1-mediated signalling / positive regulation of oligodendrocyte differentiation / positive regulation of translational initiation / CD28 dependent PI3K/Akt signaling / positive regulation of TOR signaling / response to amino acid / HSF1-dependent transactivation / regulation of macroautophagy / 'de novo' pyrimidine nucleobase biosynthetic process / cellular response to nutrient levels / vascular endothelial cell response to laminar fluid shear stress / neuronal action potential / positive regulation of lipid biosynthetic process / positive regulation of epithelial to mesenchymal transition / heart morphogenesis / regulation of cellular response to heat / positive regulation of lamellipodium assembly / cardiac muscle contraction / phagocytic vesicle / positive regulation of stress fiber assembly / T cell costimulation / cytoskeleton organization / endomembrane system / negative regulation of autophagy / cellular response to amino acid starvation / protein serine/threonine kinase activator activity / cellular response to starvation / positive regulation of glycolytic process / regulation of signal transduction by p53 class mediator / Regulation of PTEN gene transcription / post-embryonic development / positive regulation of translation / VEGFR2 mediated vascular permeability / TP53 Regulates Metabolic Genes / regulation of actin cytoskeleton organization / phosphoprotein binding / cellular response to amino acid stimulus / non-specific protein-tyrosine kinase / regulation of cell growth / macroautophagy / response to nutrient levels / regulation of circadian rhythm / protein destabilization / PML body / multicellular organism growth / cellular response to insulin stimulus / Regulation of TP53 Degradation Similarity search - Function | ||||||
Biological species | ![]() ![]() ![]() | ||||||
Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 5.9 Å | ||||||
![]() | Aylett, C.H.S. / Sauer, E. / Imseng, S. / Boehringer, D. / Hall, M.N. / Ban, N. / Maier, T. | ||||||
![]() | ![]() Title: Architecture of human mTOR complex 1. Authors: Christopher H S Aylett / Evelyn Sauer / Stefan Imseng / Daniel Boehringer / Michael N Hall / Nenad Ban / Timm Maier / ![]() Abstract: Target of rapamycin (TOR), a conserved protein kinase and central controller of cell growth, functions in two structurally and functionally distinct complexes: TORC1 and TORC2. Dysregulation of ...Target of rapamycin (TOR), a conserved protein kinase and central controller of cell growth, functions in two structurally and functionally distinct complexes: TORC1 and TORC2. Dysregulation of mammalian TOR (mTOR) signaling is implicated in pathologies that include diabetes, cancer, and neurodegeneration. We resolved the architecture of human mTORC1 (mTOR with subunits Raptor and mLST8) bound to FK506 binding protein (FKBP)-rapamycin, by combining cryo-electron microscopy at 5.9 angstrom resolution with crystallographic studies of Chaetomium thermophilum Raptor at 4.3 angstrom resolution. The structure explains how FKBP-rapamycin and architectural elements of mTORC1 limit access to the recessed active site. Consistent with a role in substrate recognition and delivery, the conserved amino-terminal domain of Raptor is juxtaposed to the kinase active site. | ||||||
History |
|
-
Structure visualization
Movie |
![]() |
---|---|
Structure viewer | Molecule: ![]() ![]() |
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 1016.8 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 817.7 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Summary document | ![]() | 1.1 MB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 1.3 MB | Display | |
Data in XML | ![]() | 137.1 KB | Display | |
Data in CIF | ![]() | 230.1 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 3213MC ![]() 3212C ![]() 5ef5C M: map data used to model this data C: citing same article ( |
---|---|
Similar structure data |
-
Links
-
Assembly
Deposited unit | ![]()
|
---|---|
1 |
|
-
Components
-SERINE/THREONINE-PROTEIN KINASE ... , 3 types, 6 molecules 1324BF
#1: Protein | Mass: 52357.672 Da / Num. of mol.: 2 / Fragment: HORN DOMAIN Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() #2: Protein | Mass: 31081.197 Da / Num. of mol.: 2 / Fragment: BRIDGE DOMAIN Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() #4: Protein | Mass: 134036.641 Da / Num. of mol.: 2 / Fragment: FAT AND PIKK DOMAINS Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() References: UniProt: P42345, non-specific serine/threonine protein kinase |
---|
-Protein , 3 types, 6 molecules AECGDH
#3: Protein | Mass: 87589.977 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() #5: Protein | Mass: 9124.238 Da / Num. of mol.: 2 / Source method: isolated from a natural source / Source: (natural) ![]() ![]() #6: Protein | Mass: 35910.090 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() |
---|
-Non-polymers , 1 types, 2 molecules 
#7: Chemical |
---|
-Experimental details
-Experiment
Experiment | Method: ELECTRON MICROSCOPY |
---|---|
EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
Component | Name: HUMAN MTOR COMPLEX 1 / Type: COMPLEX |
---|---|
Buffer solution | Name: 100 MM NACL, 10 MM NABICINE, 1 MM TCEP / pH: 8 / Details: 100 MM NACL, 10 MM NABICINE, 1 MM TCEP |
Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
Specimen support | Details: CARBON |
Vitrification | Instrument: FEI VITROBOT MARK I / Cryogen name: ETHANE Details: VITRIFICATION 1 -- CRYOGEN- ETHANE, HUMIDITY- 100, TEMPERATURE- 120, INSTRUMENT- FEI VITROBOT MARK I, METHOD- 4 SECOND BLOTTING, |
-
Electron microscopy imaging
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
---|---|
Microscopy | Model: FEI TITAN KRIOS / Date: May 5, 2015 |
Electron gun | Electron source: ![]() |
Electron lens | Mode: BRIGHT FIELD / Nominal magnification: 59000 X / Calibrated magnification: 100719 X / Nominal defocus max: 4000 nm / Nominal defocus min: 1900 nm / Cs: 2.7 mm |
Specimen holder | Temperature: 100 K |
Image recording | Electron dose: 25 e/Å2 / Film or detector model: FEI FALCON II (4k x 4k) |
-
Processing
EM software |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CTF correction | Details: EACH IMAGE | ||||||||||||||||
Symmetry | Point symmetry: C2 (2 fold cyclic) | ||||||||||||||||
3D reconstruction | Method: MAXIMUM A POSTERIORI PROJECTION MATCHING / Resolution: 5.9 Å / Num. of particles: 309792 / Nominal pixel size: 1.39 Å / Actual pixel size: 1.39 Å Details: THE UNK CHAINS (A, E, C, G, 1-4) CORRESPONDING TO RAPTOR (A,E), SF FKBP AND RAPAMYCIN (C,G) AND THE N-TERMINAL HEAT REPEATS OF MTOR (1-4), HAVE BEEN NUMBERED FROM 100 AT EACH BREAK TO ...Details: THE UNK CHAINS (A, E, C, G, 1-4) CORRESPONDING TO RAPTOR (A,E), SF FKBP AND RAPAMYCIN (C,G) AND THE N-TERMINAL HEAT REPEATS OF MTOR (1-4), HAVE BEEN NUMBERED FROM 100 AT EACH BREAK TO INDICATE LACK OF SEQUENCE - DENSITY CERTAINTY. CHAINS 1-4 CORRESPOND TO THE N-TERMINAL HEAT REPEAT DOMAINS OF MTOR. WE PROPOSE A TOPOLOGY IN THE CORRESPONDING PAPER (1-2-B AND 3-4-F), BUT GIVEN THE FACT THAT THEIR TOPOLOGY CANNOT BE ASSIGNED DEFINITIVELY THEY ARE REPRESENTED AS A SEPARATE CHAIN FOR EACH DOMAIN. THE FITTING OF CRYSTAL STRUCTURES FOR THE MTOR FAT AND PIKK DOMAINS, MLST8, RAPTOR AND FKBP ALLOWS THEIR DENSITY TO BE ASSIGNED DEFINITIVELY, AND THEIR CHAINS ARE THEREFORE LETTERED. SUBMISSION BASED ON EXPERIMENTAL DATA FROM EMDB EMD-3213. (DEPOSITION ID: 13912). Symmetry type: POINT | ||||||||||||||||
Atomic model building | Protocol: RIGID BODY FIT / Target criteria: FSC / Details: METHOD--RIGID BODY | ||||||||||||||||
Refinement | Highest resolution: 5.9 Å | ||||||||||||||||
Refinement step | Cycle: LAST / Highest resolution: 5.9 Å
|